… Mesenchymal stem cells are currently considered as a promising tool for therapeutic … kidney
injury (AKI) management. AKI is characterized by acute tubular injury with rapid loss of renal …

… There is a good deal of interest in MSC-based approaches for the treatment of human kidney
injury, thanks to positive preclinical results, the strong clinical need for novel therapies to …

… has still been no effective medical treatment. The therapeutic choices are confined … ,
mesenchymal stem cells (MSCs)-based cell therapy was proposed for the treatment of kidney injuries…

… All animals were sacrificed after 2 months of stem cell administration. After the completion
of this round, all animals were fasted for 12 h and the blood samples were collected from retro-…

… kidney injury (AKI) can result in long-term functional deficits and has been recognized as a
major contributor to chronic kidney disease … Considering the fact that mesenchymal stem cells …

… such as stem cell treatment. The story of stem cells as a mean to cure acute kidney injury (AKI…
in experimental animals mainly carried out with mesenchymal stem cells (MSC). The aim of …

… For effective MSC-based treatment of kidney disease, it is important to study the therapeutic
mechanisms of MSCs and explore ways of enhancing the efficiency of MSC-based therapy. …

… administration of exogenous MSC could prevent renal injury … to treat acute kidney injury,
chronic kidney disease, diabetic … lupus erythematosus, and kidney transplantation. The data …

… , infectious diseases, and acute kidney injury can progress to ESRD, … Current treatment
modalities often fail to target the major underlying contributors for progression of renal disease [6]…

… administration of multipotent mesenchymal stem cells (MSC) to anesthetized rats with
ischemia-reperfusion-induced ARF (40-min bilateral renal … as lower renal injury and unchanged …